Similar articles

• Interest in Rh testing and Rh immunoglobulin treatment among patients obtaining telehealth medication abortion.

  Shin LJ, Koenig LR, Ko J, Meckstroth K, Upadhyay UD. Shin LJ, et al. Contraception. 2025 Jun;146:110856. doi: 10.1016/j.contraception.2025.110856. Epub 2025 Feb 26. Contraception. 2025. PMID: 40021111
• The history of rhesus prophylaxis with anti-D.

  Wegmann A, Glück R. Wegmann A, et al. Eur J Pediatr. 1996 Oct;155(10):835-8. doi: 10.1007/BF02282831. Eur J Pediatr. 1996. PMID: 8891551 No abstract available.
• A review of the clinical effectiveness of routine antenatal anti-D prophylaxis for rhesus-negative women who are pregnant.

  Jones ML, Wray J, Wight J, Chilcott J, Forman K, Tappenden P, Beverley C. Jones ML, et al. BJOG. 2004 Sep;111(9):892-902. doi: 10.1111/j.1471-0528.2004.00243.x. BJOG. 2004. PMID: 15327601 Review. No abstract available.
• [Is it always necessary to give anti-D gamma-globulins in the case of spontaneous miscarriage in Rhesus-negative patients?].

  Salvat J, Slamani L, Capilna M, Brescu O. Salvat J, et al. Contracept Fertil Sex. 1997 Apr;25(4):V-IX. Contracept Fertil Sex. 1997. PMID: 9229512 Review. French. No abstract available.
• Targeted Rhesus immunoglobulin for RhD-negative women undergoing an induced abortion: A clinical pilot study.

  Jensen MPS, Damkjaer MB, Clausen FB, Ali HA, Hare KJ, Dziegiel MH, Jørgensen FS. Jensen MPS, et al. Acta Obstet Gynecol Scand. 2019 Sep;98(9):1164-1171. doi: 10.1111/aogs.13606. Epub 2019 Apr 1. Acta Obstet Gynecol Scand. 2019. PMID: 30860294